Our mission is to improve the success of surgeries by enabling surgeons better to distinguish different tissue types and identify malignant lesions. Our proprietary technology enables multiparametric endoscopy where various structural and functional images are provided simultaneously.
The first application of our real-time multispectral imaging technology is in transurethral resections of bladder tumor (TURBT), where we expect it will contribute to reducing disease recurrence and minimizing collateral tissue damage.
rMSI technology offers the ability to differentiate optically and intuitively whether tissue is malignant or healthy. Surgeons may thus for the first time be able to greatly improve the success rate of operation, improve post-surgery prognosis and in the long term increase the average life expectancy.
👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…
Founded in Mauritius in 2004, providing a full suite of services. These services range from…
Skinobs Revamps “We Are Testing” with a bold new identity and website ahead of NYSCC…